Loading…
Central Vapors and Central Vapors LLC was cited for offering electronic nicotine delivery system (ENDS) products for sale without required premarket authorization, violating the Federal Food, Drug, and Cosmetic Act and FDA tobacco product regulations. The company's website was found to be distributing tobacco products—including those containing nicotine from non-tobacco sources, which fall under FDA jurisdiction following the 2022 expansion of tobacco product definitions—without the legally mandated premarket approval orders. The violations stemmed from the company's failure to comply with FDA requirements applicable to new tobacco products under section 901(b) of the FD&C Act and implementing regulations.